EGFR and breast carcinoma: Using in silico approaches, including molecular docking, ADMET profiling, molecular dynamics simulations, and MM-GBSA binding free energy calculations, this study assesses the binding affinity, pharmacokinetic properties, dynamic stability, and therapeutic potential of these compounds against EGFR in breast cancer.